New study aims to reduce unnecessary liver specialist referrals
NCT ID NCT04435054
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 1,000 people aged 40-80 with type 2 diabetes or obesity to find the best way to screen for advanced liver scarring (fibrosis) from fatty liver disease. Researchers tested combinations of blood tests and a special ultrasound (FibroScan) to see which approach most accurately identifies those who truly need a liver specialist. The goal is to reduce unnecessary referrals and make screening more efficient.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-ALCOHOLIC FATTY LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Nantes
Nantes, France
-
Centre Hospitalier Universitaire Dijon Bourgogne
Dijon, France
-
Hôpital Lyon Sud
Pierre-Bénite, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could immune cells in fat hold the key to Obesity-Related disease?
- A new MRI technique could see inside the Liver's metabolism without a biopsy
- Can Weight-Loss surgery beat drugs for advanced liver damage?
- Can fatty liver in children lead to serious liver disease? a Long-Term study aims to find out
- Can a scan replace the needle? ultrasound and MRI put to the test against liver biopsy for fatty liver disease
- Can fish oil shrink a fatty liver?